During the last two decades, several attempts to enhance NK cell functions as a therapy for the treatment of AML or other cancers have been tested including the stimulation in vitro or in vivo by γc cytokines (IL-2, IL-15, IL-21, etc.). Here, IL21 is linked to acute myeloid leukemia.